"Confirmatory" trials: symptom reduction as efficacy measure.
James
J S
JS
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000458:organization & administration*; D011480:Protease Inhibitors / Q000627:therapeutic use; D011643:Publishing; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D011480:Protease Inhibitors